Patients with LORA and CLD at baseline had lower rates of treatment response and a higher risk for SAEs over 5 years, compared against those without CLD.
Less than three-quarters of medical device-related adverse events are reported on time by their manufacturers.
In patients with CKD, hyperkalemia significantly increases risk for major adverse cardiovascular events and arrhythmia.
Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality ...
The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...
During a live event, James W. Smithy, MD, MHS, and other oncologists discussed how their experience with immune-related ...
Attorney Simon Purnell of Griffin Purnell said he thinks the courts' view of preemption is a "fundamental misunderstanding of ...
Sarepta stock may recover sharply as additional information and data reveal that the adverse event reported by the company is ...
To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as ...
A treat-to-target study of upadacitinib in atopic dermatitis showed that dosing can be adjusted depending on early patient ...
A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events among those treated with zanubrutinib compared with ibrutinib.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback